Detection of epidermal growth factor receptor mutations in peripheral blood circulating tumor DNA in patients with advanced non-small cell lung cancer: A PRISMA-compliant meta-analysis and systematic review

BACKGROUND: The epidermal growth factor receptor (EGFR) mutation status related to the treatment approach for advanced non-small cell lung cancer (NSCLC) patients. This study aimed to evaluate the diagnostic accuracy of peripheral blood circulating tumor DNA (ctDNA) in EGFR mutated advanced NSCLC pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shunkai, Huang, Rongzhi, Cao, Yunpeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535563/
https://www.ncbi.nlm.nih.gov/pubmed/33019389
http://dx.doi.org/10.1097/MD.0000000000021965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7535563/
https://www.ncbi.nlm.nih.gov/pubmed/33019389
http://dx.doi.org/10.1097/MD.0000000000021965

Ejemplares similares